目前缺血性脑卒中常用量表广泛应用于临床及科研中,了解和使用这些量表成为现在神经科医生不可缺少的工作内容。本文主要介绍目前临床常用的脑卒中相关量表,包括ABCD2评分、美国国立卫生研究院卒中量表(national institute of health st...目前缺血性脑卒中常用量表广泛应用于临床及科研中,了解和使用这些量表成为现在神经科医生不可缺少的工作内容。本文主要介绍目前临床常用的脑卒中相关量表,包括ABCD2评分、美国国立卫生研究院卒中量表(national institute of health stroke scale,NIHSS)、Rankin修订量表(mRS)和Barthel指数量表及其他卒中相关量表。展开更多
Cattle encephalon glycoside and ignotin(CEGI)injection is a compound preparation formed by a combination of muscle extract from hea lthy rabbits and brain gangliosides from cattle,and it is generally used as a neuropr...Cattle encephalon glycoside and ignotin(CEGI)injection is a compound preparation formed by a combination of muscle extract from hea lthy rabbits and brain gangliosides from cattle,and it is generally used as a neuroprotectant in the treatment of central and peripheral nerve injuries.However,there is still a need for high-level clinical evidence from large samples to support the use of CEGI.We therefore carried out a prospective,multicenter,randomized,double-blind,parallel-group,placebo-controlled study in which we recruited 319 patients with acute cerebral infarction from 16 centers in China from October 2013 to May 2016.The patients were randomized at a 3:1 ratio into CEGI(n=239;155 male,84 female;61.2±9.2 years old)and placebo(n=80;46 male,34 female;63.2±8.28 years old)groups.All patients were given standard care once daily for 14 days,including a 200 mg aspirin enteric-coated tablet and 20 mg atorvastatin calcium,both taken orally,and intravenous infusion of 250–500 mL 0.9%sodium chloride containing 40 mg sodium tanshinone IIA sulfonate.Based on conventional treatment,patients in the CEGI and placebo groups were given 12 mL CEGI or 12 mL sterile water,respectively,in an intravenous drip of 250 mL 0.9%sodium chloride(2 mL/min)once daily for 14 days.According to baseline National Institutes of Health Stroke Scale scores,patients in the two groups were divided into mild and moderate subgroups.Based on the modified Rankin Scale results,the rate of patients with good outcomes in the CEGI group was higher than that in the placebo group,and the rate of disability in the CEGI group was lower than that in the placebo group on day 90 after treatment.In the CEGI group,neurological deficits were decreased on days 14 and 90 after treatment,as measured by the National Institutes of Health Stroke Scale and the Barthel Index.Subgroup analysis revealed that CEGI led to more significant improvements in moderate stroke patients.No drug-related adverse events occurred in the CEGI or placebo groups.In conclusion,CEGI may be a 展开更多
Low frequency （≤ 1 Hz） repetitive transcranial magnetic stimulation （rTMS） can affect the excitability of the cerebral cortex and synaptic plasticity. Although this is a common method for clinical treatment of ce...Low frequency （≤ 1 Hz） repetitive transcranial magnetic stimulation （rTMS） can affect the excitability of the cerebral cortex and synaptic plasticity. Although this is a common method for clinical treatment of cerebral infarction, whether it promotes the recovery of motor function remains controversial. Twenty patients with cerebral infarction combined with hemiparalysis were equally and randomly divided into a low frequency rTMS group and a control group. The patients in the low frequency rTMS group were given 1-Hz rTMS to the contralateral primary motor cortex with a stimulus intensity of 90% motor threshold, 30 minutes/day. The patients in the control group were given sham stimulation. After 14 days of treatment, clinical function scores （National Institute of Health Stroke Scale, Barthel Index, and Fugl-Meyer Assessment） improved significantly in the low frequency rTMS group, and the effects were better than that in the control group. We conclude that low frequency （1 Hz） rTMS for 14 days can help improve motor function after cerebral infarction.展开更多
目的:观察"通督调神针法"与常规针刺治疗急性脑梗死患者的临床疗效差异及其与自噬的关系。方法:将60例急性脑梗死患者分为观察组(30例,2例脱落)与对照组(30例,3例脱落)。两组均采用常规药物治疗。观察组穴取大椎、风池、强间...目的:观察"通督调神针法"与常规针刺治疗急性脑梗死患者的临床疗效差异及其与自噬的关系。方法:将60例急性脑梗死患者分为观察组(30例,2例脱落)与对照组(30例,3例脱落)。两组均采用常规药物治疗。观察组穴取大椎、风池、强间、百会、神庭、印堂、水沟、曲池(患侧)、合谷(患侧)、足三里(患侧),将百会和印堂连接电针仪,30 min后去除电针及非督脉穴位针,继续留督脉穴位针20 min,每隔5 min捻转1次,每次1 min。对照组穴取百会、印堂、曲池(患侧)、外关(患侧)、手三里(患侧)、合谷、足三里、三阴交(患侧)、太溪(患侧)、太冲(患侧),足三里、合谷加电针仪,每次留针30 min。每天治疗1次,连续治疗10 d。观察两组患者治疗前后美国国立卫生院神经功能缺损评分量表(National Institute of Health stroke scale,NIHSS)、简易智能精神状态检查量表(mini-mental state examimation,MMSE)、改良Barthel指数(modified Barthel index,MBI)评分,并评定外周血清中微管相关蛋白1轻链3-Ⅱ(LC3-Ⅱ)和自噬相关蛋白Beclin1表达量的变化及临床疗效。结果:治疗后两组NIHSS评分均低于治疗前,MBI评分、MMSE评分均高于治疗前(均P<0.01),且观察组均优于对照组(均P<0.05)。治疗后两组患者LC3-Ⅱ、Beclin1表达量均高于治疗前(均P<0.01),且观察组均高于对照组(均P<0.05)。治疗后观察组总有效率为92.9%(26/28),优于对照组的70.4%(19/27,P<0.05)。结论:"通督调神针法"减轻急性脑梗死患者临床症状优于常规针刺,可能与自噬体数量增加、自噬活性增强有关。展开更多
文摘目前缺血性脑卒中常用量表广泛应用于临床及科研中,了解和使用这些量表成为现在神经科医生不可缺少的工作内容。本文主要介绍目前临床常用的脑卒中相关量表,包括ABCD2评分、美国国立卫生研究院卒中量表(national institute of health stroke scale,NIHSS)、Rankin修订量表(mRS)和Barthel指数量表及其他卒中相关量表。
文摘Cattle encephalon glycoside and ignotin(CEGI)injection is a compound preparation formed by a combination of muscle extract from hea lthy rabbits and brain gangliosides from cattle,and it is generally used as a neuroprotectant in the treatment of central and peripheral nerve injuries.However,there is still a need for high-level clinical evidence from large samples to support the use of CEGI.We therefore carried out a prospective,multicenter,randomized,double-blind,parallel-group,placebo-controlled study in which we recruited 319 patients with acute cerebral infarction from 16 centers in China from October 2013 to May 2016.The patients were randomized at a 3:1 ratio into CEGI(n=239;155 male,84 female;61.2±9.2 years old)and placebo(n=80;46 male,34 female;63.2±8.28 years old)groups.All patients were given standard care once daily for 14 days,including a 200 mg aspirin enteric-coated tablet and 20 mg atorvastatin calcium,both taken orally,and intravenous infusion of 250–500 mL 0.9%sodium chloride containing 40 mg sodium tanshinone IIA sulfonate.Based on conventional treatment,patients in the CEGI and placebo groups were given 12 mL CEGI or 12 mL sterile water,respectively,in an intravenous drip of 250 mL 0.9%sodium chloride(2 mL/min)once daily for 14 days.According to baseline National Institutes of Health Stroke Scale scores,patients in the two groups were divided into mild and moderate subgroups.Based on the modified Rankin Scale results,the rate of patients with good outcomes in the CEGI group was higher than that in the placebo group,and the rate of disability in the CEGI group was lower than that in the placebo group on day 90 after treatment.In the CEGI group,neurological deficits were decreased on days 14 and 90 after treatment,as measured by the National Institutes of Health Stroke Scale and the Barthel Index.Subgroup analysis revealed that CEGI led to more significant improvements in moderate stroke patients.No drug-related adverse events occurred in the CEGI or placebo groups.In conclusion,CEGI may be a
基金supported by the National Natural Science Foundation of China,No.30540058,30770714the Natural Science Foundation of Beijing of China,No.7052030+2 种基金the Talents Foundation of Organization Department of the Beijing Municipal Committee in Chinathe Beijing Science Plan Project Fund of China,No.Z0005187040191-1the Research Foundation of Capital Medical Development of China,No.2007-2068
文摘Low frequency （≤ 1 Hz） repetitive transcranial magnetic stimulation （rTMS） can affect the excitability of the cerebral cortex and synaptic plasticity. Although this is a common method for clinical treatment of cerebral infarction, whether it promotes the recovery of motor function remains controversial. Twenty patients with cerebral infarction combined with hemiparalysis were equally and randomly divided into a low frequency rTMS group and a control group. The patients in the low frequency rTMS group were given 1-Hz rTMS to the contralateral primary motor cortex with a stimulus intensity of 90% motor threshold, 30 minutes/day. The patients in the control group were given sham stimulation. After 14 days of treatment, clinical function scores （National Institute of Health Stroke Scale, Barthel Index, and Fugl-Meyer Assessment） improved significantly in the low frequency rTMS group, and the effects were better than that in the control group. We conclude that low frequency （1 Hz） rTMS for 14 days can help improve motor function after cerebral infarction.
文摘目的:观察"通督调神针法"与常规针刺治疗急性脑梗死患者的临床疗效差异及其与自噬的关系。方法:将60例急性脑梗死患者分为观察组(30例,2例脱落)与对照组(30例,3例脱落)。两组均采用常规药物治疗。观察组穴取大椎、风池、强间、百会、神庭、印堂、水沟、曲池(患侧)、合谷(患侧)、足三里(患侧),将百会和印堂连接电针仪,30 min后去除电针及非督脉穴位针,继续留督脉穴位针20 min,每隔5 min捻转1次,每次1 min。对照组穴取百会、印堂、曲池(患侧)、外关(患侧)、手三里(患侧)、合谷、足三里、三阴交(患侧)、太溪(患侧)、太冲(患侧),足三里、合谷加电针仪,每次留针30 min。每天治疗1次,连续治疗10 d。观察两组患者治疗前后美国国立卫生院神经功能缺损评分量表(National Institute of Health stroke scale,NIHSS)、简易智能精神状态检查量表(mini-mental state examimation,MMSE)、改良Barthel指数(modified Barthel index,MBI)评分,并评定外周血清中微管相关蛋白1轻链3-Ⅱ(LC3-Ⅱ)和自噬相关蛋白Beclin1表达量的变化及临床疗效。结果:治疗后两组NIHSS评分均低于治疗前,MBI评分、MMSE评分均高于治疗前(均P<0.01),且观察组均优于对照组(均P<0.05)。治疗后两组患者LC3-Ⅱ、Beclin1表达量均高于治疗前(均P<0.01),且观察组均高于对照组(均P<0.05)。治疗后观察组总有效率为92.9%(26/28),优于对照组的70.4%(19/27,P<0.05)。结论:"通督调神针法"减轻急性脑梗死患者临床症状优于常规针刺,可能与自噬体数量增加、自噬活性增强有关。
